- Champignon Brands recently started trading on the Canadian Securities Exchange (CSE)
- The company also enters into definitive agreement to acquire Artisan Growers Ltd
- SHRM specializes in medicinal-mushroom, mushroom-infused products
Champignon Brands Inc. (CSE: SHRM), a wellness company specializing in the formulation and distribution of a group of artisanal-mushroom health supplements, recently began trading on the Canadian Securities Exchange (CSE). In February 2020, SHRM successfully completed an initial public offering (IPO) through lead agent PI Financial Corp. Additionally, Champignon Brands will look to secure a listing on the Frankfurt Stock Exchange and a quotation on the OTC Marketplace in the United States as soon as is feasible (http://ibn.fm/SzJuo).
“We’ve been assembling a dedicated roster of mycologists and health and wellness professionals to formulate several distinctive lines of premium fungi extracts,” Champignon CEO Gareth Birdsall stated in a news release. “The overall product portfolio is tailored for conscious consumers looking to support mental health and bolster cognitive performance through medicinal mushroom-based products.”
As Champignon Brands continues to bolster its product portfolio, the company also recently announced that it entered into a definitive agreement to acquire Artisan Growers Ltd., a British-Columbia-based, craft-mushroom cultivator and supplier. Champignon’s plan is to integrate Artisan Growers’ craft-mushroom production capacity into its existing medicinal-mushroom manufacturing, formulation and distribution infrastructure.
Champignon Brands’ focus is to continue to control its supply chain directly to the end user (http://ibn.fm/LLtPq). Artisan Growers operates a craft-mushroom cultivation facility that can produce an array of organic craft mushroom varietals including lion’s mane, chaga, reishi and agaricus blazei.
SHRM’s dedication is to the cultivation, distribution and proliferation of artisanal-medical mushrooms and associated CPGs (Consumer Packaged Goods). The company crafts its increasingly evolving portfolio with the health-conscious consumer in mind, as evidenced by its flagship brand, Vitality Superteas. A vertically integrated producer of medicinal mushrooms and related products, Champignon Brands is based in Vancouver, British Columbia.
With a passion for transforming conventional organic teas, coffees and other consumables with the infusion of a proprietary blend of artisanal mushrooms, SHRM and its offerings align with the medical research community’s renewed interest in mushrooms’ health benefits. “Mushrooms contain protein, vitamins, minerals, and antioxidants. These can have various health benefits,” reported a recent Medical News Today article titled ‘What is the Nutritional Value of Mushrooms?’ (http://ibn.fm/Q7xCB). The article also states that “the antioxidant content in mushrooms may help prevent lung, prostate, breast and other types of cancer, according to the National Cancer Institute.” Harnessing the power of the humble mushroom, Champignon Brands is helping to shape the health and wellness product landscape. Champignon Brands has its premium family of organic, sustainable, vegan and non-GMO (genetically modified organisms) mushroom and mushroom-infused formulations. The company’s Vitality Superteas products includes Nourish Force Supertea, a blend of reishi tyobus tea mix; Mighty Recharge Supertea, created with lion’s mane tropical green ginseng tea mix; and Brain Enhance Supertea, a blend of cordycep hibiscus and berries tea mix.
Aside from its impressive product lineup, the company also has its research and development/product formulation partnership. Champignon and Drip Coffee Social Ltd. entered into this partnership to facilitate Drip Coffee Social infusing Champignon’s proprietary, mushroom-extract blend into a suite of cold-brew coffee products and signature in-house formulations (http://ibn.fm/86VgL). Champignon sees considerable potential in the CPG space.
The expectation is that the worldwide, functional-food marketplace that the company is working to enter will reach $34.3 billion by 2024. For 2020, Champignon Brands’ strategy includes the development of cGMP (Current Good Manufacturing Practice) formulations of bioactive compounds extracted from plants and fungi (http://ibn.fm/Z9gd7).
Champignon Brands is aggressively pursuing its mission of researching and distributing premium-medicinal, mushrooms-infused products. Of note to investors is that the company is targeting high-margin markets and optimizing its e-commerce and fulfillment infrastructure. Champignon Brands continues to promote the health and wellness benefits of functional mushrooms while at the same time offering the potential for significant investor return on investment.
For more information, visit the company’s website at www.ChampignonBrands.com
NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://ibn.fm/SHRM
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.